I1DX34:BVMF
Idexx Laboratories Inc Bdr
516,36Â R$
0,00%
(0,00) 1 p
9. okt, 13:31:01 GMT −3 · BRL
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse I1DX34 põhistatistika genereerimine…
Turu kapit.
40,99Â mld
Keskm. maht
6,00
Maht
0,00
52 näd kõrgeim
813,60Â R$
52 näd madalaim
509,99Â R$
Käibivad aktsiad
78,78Â mln
Töötajate arv
11Â tuh
Turu kapit.
40,99Â mld
Keskm. maht
6,00
Maht
0,00
52 näd kõrgeim
813,60Â R$
52 näd madalaim
509,99Â R$
Käibivad aktsiad
78,78Â mln
Töötajate arv
11Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Investing.com
·
1 päeva eest
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Profiil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Teave üksuse Idexx Laboratories Inc Bdr kohta
TegevjuhtJay Mazelsky
Töötajad11 tuh
Asutatud19. dets 1983
PeakontoridWestbrook, Maine, Ameerika Ãœhendriigid
Sektor-
Veebisaitidexx.com